论文部分内容阅读
1991年11月5～12日,中国药学会在北京举办了第二期《全国新药审批与药学新进展》研讨班。其间得到了国家医药管理局、中国科协、中国药品生物制品检定所,卫生部新药审评办公室等单位的大力支持。《新药审批办法》虽实行6年,但毕竟是个新工作,为促使我国新药的开发及医药工业的发展,应国内生产及研制新药单
From November 5 to December 12, 1991, the Chinese Pharmaceutical Association held a second seminar on “New Approvals and New Advances of New Drugs in China” in Beijing. In the meantime, it has received strong support from the State Administration of Medicine, China Association for Science and Technology, China Pharmaceutical and Biological Products Inspection Office and the Office of Drug Review and Evaluation of the Ministry of Health. Although the Measures for the Examination and Approval of New Drugs have been implemented for six years, it is a new job after all. In order to promote the development of new drugs and the development of the pharmaceutical industry in our country, a new drug bill should be domestically produced and developed